Beranda › Limfoma Sel B › Colorado › Aurora
Uji klinis Limfoma Sel B di Aurora, CO
6 studi untuk Limfoma Sel B mencari peserta di lokasi sekitar Aurora (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
- Children's Hospital Colorado, Aurora
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
Menerima pesertaFase 1/2
- Children's Hospital Colorado, Aurora
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Menerima pesertaFase 1/2
- Rocky Mountain Cancer Centers, Aurora
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Menerima pesertaFase 3
- University of Colorado, Aurora
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
Menerima pesertaFase 1
- University of Colorado Hospital, Aurora
Uji klinis Limfoma Sel B di kota lain
- New York City, NY19 studi
- Houston, TX16 studi
- Chicago, IL12 studi
- Nashville, TN11 studi
- Philadelphia, PA11 studi
- Rochester, MN10 studi
- Baldwin Park, CA9 studi
- Milwaukee, WI9 studi
- Cleveland, OH9 studi
- Salt Lake City, UT8 studi
- Boston, MA8 studi
- Columbus, OH7 studi
Studi lain di Aurora
- Kanker (semua jenis)35 studi
- Kanker Kolorektal32 studi
- Kanker Paru Non-Sel Kecil30 studi
- Kanker Payudara27 studi
- Kanker Metastatik25 studi
- Kanker Ovarium25 studi
- Diabetes Tipe 123 studi
- Obesitas21 studi
- Kanker Paru19 studi
- Kanker Prostat19 studi
- Gagal Jantung18 studi
- Melanoma18 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.